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Abstract
Objective: Palliative and hospice care have been shown to benefit people with dementia and their
families. However, for patients with dementia who are nearing the end of life, hospice referral
can be challenging because of the difficulty in predicting prognosis. The objective of this
retrospective, exploratory study is two-fold: (1) to describe trajectories by analyzing trends in
Palliative Performance Scale (PPS) scores for patients admitted to hospice with a neurocognitive
disorder from time of enrollment to time of disenrollment and (2) to determine the relationship
between PPS and length of stay (LOS) in hospice care.
Methods: The setting for the study is a geriatrics clinic in west central Ohio. Data collection
utilized the Athena™ EMR to identify patients with a neurocognitive disorder who were enrolled
in a home-based hospice program between January 1, 2015 and December 31, 2018. PPS scores
for 55 patients were recorded from periodic hospice documents submitted to the attending
physicians in the geriatrics clinic and from progress notes entered by the geriatricians, as they comanaged the patients alongside hospice.
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Results: Fifty-five patients received care across five hospices during the study period. Of those
included, 22 had a primary diagnosis of Alzheimer's dementia, and 33 had vascular dementia.
The median length of stay in hospice care was 93 days, with death being the reason for discharge
in all but one patient. Median length of stay decreased incrementally with each decrease in initial
PPS score. With regard to PPS changes over time, there was wide variability in individual
trajectories, which demonstrates the highly variable and unpredictable nature of dementia.
Almost three quarters of the study population died prior to the 6-month mark in hospice care,
suggesting that patients with dementia may be receiving hospice care later than they qualify.
Key Words: palliative; performance; scale; hospice; dementia; Alzheimer; prognosis
Introduction/Literature Review
Dementia
Dementia is a diagnosis that encompasses numerous etiologies and shows variable
expression among patients. It is becoming more prevalent every year. In 2017, the World Health
Organization estimated that about 50 million people worldwide have some form of dementia,
with approximately 10 million new cases each year.1 It is a progressive and incurable disease.
Despite the increasing number of cases and severity of symptoms, patients with advanced forms
of dementia are underrepresented in palliative care compared to those with other diagnoses.2
There are several reasons why this may be the case, including ambiguities in eligibility criteria
and difficulties in classifying disease stages.
When it comes to terminal illnesses like end-stage dementia, palliative care is crucial for
maintaining comfort and quality of life throughout the dying process. Surveys completed by
relatives of deceased patients with dementia reported increased quality of care, fewer unmet
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needs, and greater emotional support while in hospice care compared to non-hospice care.3 In
2018, Harrop et al. created a program to provide social workers and peer groups to patients and
families receiving palliative care. Outcomes included self-reported improvements for patients
and caregivers alike, including fewer cases of isolation and an improved sense of feeling “at
home” among patients.4 Despite the apparent benefits of hospice, gaining access to palliative care
for patients with dementia can be complex, especially in the early stages of disease.
Hospice Eligibility and Prognosis
The majority of deaths in older patients with dementia occur in the setting of a nursing
facility.2 However, it has been shown that patients with advanced dementia in nursing facilities
who receive hospice care have lower risks of dying in the hospital.5 The spectrum of patients
served by hospice is evolving, and every disease has a unique progression. This variability makes
it difficult to establish specific criteria for hospice enrollment. Hospice eligibility has been a
dynamic and sometimes controversial issue. As such, there have been studies that analyze
hospice eligibility requirements and their role in patient care.
Current hospice eligibility for people with dementia is based on etiology and FAST
(functional assessment screening tool) scores. Shown in Table 1, FAST is a scale from 1 to 7
derived from a standardized instrument, with one being “normal” aging, and seven being
advanced dementia. Most guidelines today require that a patient is FAST stage 7a or greater,
which implies severe dementia. These patients are mainly non-ambulatory or have limited ability
to speak. Recent studies have shown that this assessment alone is not sufficient to indicate
prognosis in patients with dementia.6
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Stage
1 - Normal Aging
2 - Possible MCI*
3 - MCI
4 - Mild Dementia
5 - Moderate Dementia
6a - Moderately Severe
Dementia
6b - Moderately Severe
Dementia
6c - Moderately Severe
Dementia
6d - Moderately Severe
Dementia
6e - Moderately Severe
Dementia
7a - Severe Dementia
7b - Severe Dementia
7c - Severe Dementia
7d - Severe Dementia
7e - Severe Dementia
7f - Severe Dementia
Table 1: FAST Scale

Characteristic
No subjective or objective difficulty
Subjective functional deficit
Objective functional deficit, interferes with complex tasks
Deficits in IADLs
Needs help selecting proper attire
Needs help dressing
Needs help bathing
Needs help toileting
Urinary incontinence
Fecal incontinence
Ability to speak limited (1 to 5 words a day)
All intelligible vocabulary lost
Unable to ambulate without assistance
Unable to sit up without assistance
Unable to smile
Unable to hold head up

*MCI = Mild Cognitive Impairment
Prognosis is determined by numerous factors, including marital status, dementia-driven
symptoms such as anorexia, and comorbidities like hypertension, stroke, and diabetes mellitus.7
The Advanced Dementia Prognostic Tool (ADEPT) has been an alternative way to estimate
prognosis. In 2010, Mitchell et al. aimed to determine reliability of this tool in the nursing home
setting. The conclusion was that ADEPT was modestly better at predicting a 6-month survival
time than hospice eligibility guidelines.8 The results of this study, combined with results of
studies on FAST, show that current eligibility guidelines are lacking when it comes to prognosis
for patients with dementia. In terms of LOS in hospice care, a longitudinal study in 2017 found
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that the mean length of stay in hospice for those without a primary diagnosis of dementia versus
those whose primary diagnosis was dementia was 74 days and 112 days, respectively.9
Palliative Performance Scale
The palliative performance scale (PPS) was created in 1994 by Anderson, et al. as a
modification of the Karnofsky Performance Scale. It was established due to an increasing need to
assess functional capacity and decline in patients receiving palliative care.10 The scale works on
a percentage basis and declines by increments of ten. One hundred percent represents a person
whose medical condition does not affect overall functioning, while zero represents death. Table 2
shows PPS descriptors, as adapted from The Victoria Hospice Society. Today, the scale
functions on two levels. Not only does it act as a reference for the assessment of a patient’s status
and prognosis, but it is also used to assess hospice eligibility across a spectrum of relevant
diseases.
PPS

Ambulation

Activity &
Evidence of
Disease
Normal activity &
work
No evidence of
disease

Self-Care

Intake

Level of
Consciousness

100%

Full

Full

Normal

Full

90%

Full

Normal activity &
work
Some evidence of
disease

Full

Normal

Full

80%

Full

Normal activity
with effort
Some evidence of
disease

Full

Normal or
Reduced

Full

70%

Reduced

Unable to do
normal work
Significant disease

Full

Normal or
Reduced

Full
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60%

Reduced

Unable to do
hobby/housework
Significant disease

Occasional
assistance
necessary

Normal or
Reduced

Full or
Confusion

50%

Mainly sit/lie

Unable to do any
work
Extensive disease

Considerable
assistance
required

Normal or
Reduced

Full or
Confusion

40%

Mainly in bed

Unable to do most
activities
Extensive disease

Mainly
assistance

Normal or
Reduced

Full or Drowsy
+/- Confusion

30%

Totally bed
bound

Unable to do any
activity
Extensive disease

Total Care

Normal or
Reduced

Full or Drowsy
+/- Confusion

20%

Totally bed
bound

Unable to do any
activity
Extensive disease

Total Care

Minimal to
sips

Full or Drowsy
+/- Confusion

10%

Totally bed
bound

Unable to do any
activity
Extensive disease

Total Care

Mouth care
only

Drowsy or Coma
+/- Confusion

-

-

-

0%
Death
Table 2: PPS descriptors

-

Due to the emergence of literature, the PPS has become an addition to assessments used
for hospice eligibility. Myers et al. concluded that specific PPS stages in patients with advanced
cancer can be used for conducting key care discussions among patients and clinicians.11 These
discussions help direct medical decisions to provide the highest quality care. Palliative
performance scale, unlike ADEPT, is not specifically for dementia; it can be used to assess
patient functioning at the end of life due to any cause. In a study by Jansen et al., initial PPS
score was compared between those with dementia and those with other diagnoses. It was found
that although most patients in both groups died within three months, PPS score at time of
enrollment for patients with dementia varied by as much as 60%.12 In a separate study, Lo et al.
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concluded that patients with a diagnosis of advanced dementia had lower PPS scores on average
than patients with other diagnoses. Despite this, there appeared to be no difference in LOS
between the two groups.13 Studies like these endorse the idea that prognosis for people with
dementia is particularly difficult to predict when compared to other diseases.
Although the PPS has been increasingly studied in recent years, there are gaps in the
literature regarding its utilization in clinical practice. For patients with dementia, there is
literature regarding PPS status at time of hospice admission, but little exists for how these scores
change throughout the length of care. By analyzing PPS status throughout a patient’s entire time
with hospice, trends may become apparent in functional decline. In this way, the PPS may be
used as an additional tool for prognosis prediction in complex disease processes like dementia to
ensure that patients are getting quality end-of-life care in a timely manner.
Conclusion
The goal of this study is to track PPS scores in patients with dementia from time of hospice
enrollment until the end of care. Final PPS scores will also be compared to specific outcomes of
care and length of stay with hospice. By analyzing trends in functional decline, insight may be
gained into prognosis for dementia. As such, the utilization of PPS scores may alter important
care decisions, including appropriate timing for hospice enrollment.
Specific Aims:
1. Determine PPS at time of hospice enrollment for Wright State Physicians Geriatrics clinic
patients with major neurocognitive disorder.
2. Describe PPS trajectories from enrollment to time of discharge from hospice because of death,
extended prognosis, or family decision to dis-enroll.
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3. Determine the relationship between PPS and length of stay (LOS) in hospice care.
Methods
Context/Protocol
The setting for this study is a geriatrics clinic in a faculty practice affiliated with a
community-based medical school. The 55 subjects included in the study are patients from the
Wright State Physicians Geriatrics clinic whose information is extracted from Athena EMR.
Patients with a diagnosis of dementia who were enrolled in a home-based hospice program
between January 1, 2015 and December 31, 2018 were included. The diagnosis of dementia
includes Alzheimer’s disease, frontotemporal lobar degeneration, Lewy body disease, and
vascular dementia. Patients without a primary diagnosis of any of the above were excluded from
the data group.
Data Collection
Following IRB approval, data was gathered on the number of patients from the geriatrics
practice admitted to hospice, their PPS at admission, and discharge information. PPS was
determined by chart review from initial hospice evaluation and intermittent and final hospice
reports. These assessments of patient function are based on information from patients
themselves, a knowledgeable informant, and a healthcare professional skilled in the diagnosis of
dementia. Additionally, formal neuropsychological testing or the MOCA (Montreal Cognitive
Assessment) had provided objective support for a major neurocognitive disorder. The observed
cognitive deficits have been determined to interfere initially with performance in all IADLs,
followed by increasing dependence in ADLs. Finally, the impact of comorbidities on overall
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functional status was taken into account. While compiling this data, there was no direct
interaction with patients, and confidentiality was maintained by use of a number system.
Data Analysis
Univariate procedures included means, medians, and counts. PPS scores were compiled
for each patient over time, and each individual’s trajectory was plotted on one graph. All patients
were compiled together in one figure to visually display trends. Group trends were displayed
using LOESS smoothing to account for the visually nonlinear form of the trajectories. A test for
trend with PPS scores and LOS was conducted using a general linear model with PPS score
group entered as a continuous variable and LOS as the outcome variable (normality of the data
distribution was assumed for this test). Data analysis was completed with Dr. Peterson, a
geriatric researcher, using SAS version 9.4.
Results
The study population of 55 subjects included 35 women and 20 men, with an average age
of 85 years old. Twenty-two had a primary diagnosis of Alzheimer's dementia, while 33 had
vascular dementia. The median length of enrollment in hospice across all patients was 93 days,
or about three months. For the population with Alzheimer’s and vascular dementia, average LOS
was 114 and 120, respectively. In terms of comorbidities, 35 patients had concurrent
hypertension, 15 had a history of stroke, and 24 had coronary artery disease. Diabetes was
present in 8 patients, and 11 had atrial fibrillation. Ten patients had concurrent Parkinson-like
symptoms, which may be related to side effects of antipsychotic medications or to Parkinson’s
disease. Regarding outcomes, one patient was discharged due to extended prognosis, while all
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others were disenrolled due to death. Two patients included in data analysis are still currently
enrolled in hospice care, and do not have discharge information to include.
For PPS, admitting scores ranged from 40 to 10, with an average of 22. At discharge,
values ranged from 30 to 0, with an average of 9.6. Table 3 shows the initial PPS scores and their
corresponding mean and median LOS in hospice care. There was a significant linear trend (P <
0.0001) associated with lower initial PPS and shorter LOS. For the 10 patients with Parkinson’s
disease, average LOS was below the mean at 83 days.
Initial PPS

n

Mean/median LOS

10

20

31.65/18.5

20

11

130.6/106

30

17

164.7/148

40

6

226.7/251

Table 3: Initial PPS and corresponding LOS
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Figure 1 illustrates PPS trajectories for each individual patient. The bolded line gives a
trajectory for the group as a whole. From this figure, it is evident that there is an initial drop in
PPS within the first month of care, while values level off thereafter.

PPS Score
40

PPS Score
40

35

35

30

30

25

25

20

20

15

15

10

10

5

5

0

0
0

50

100

150

200

250

300

Time in Days

Figure 1: PPS trajectories
Table 4 provides details about the 6 patients (3 men and 3 women) who had a PPS of 40 at
the time of enrollment. Patient A had a length of stay of 73 days while the length of stay for each
of the remaining 5 patients was over 200 days. Caregiver stress was a prominent feature among 5
of the 6 patients with a PPS of 40 at the time of enrollment, with patient sleep disturbance being
a key contributor to caregiver stress.
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Patient Age

Gender

Diagnosis Comment

A

91

M

Vascular

Sleep disturbance due to OSA and inability to use
CPAP; CHF; repetitive vocalizations; caregiver stress
(younger spouse)

B

90

F

Vascular

Recurrent episodes of pancreatitis; CHF; intermittent
dysphagia; slowly decreasing albumin level; sleep
disturbance; caregiver stress (daughter)

C

74

F

AD

Slow weight loss; frequent falls; frightening
delusions/hallucinations; sleep disturbance (no
caregiver stress as spouse, 2 daughters, and 1
granddaughter shared caregiving)

D

96

F

Vascular

PVD with recurrent arterial ulcers; painful peripheral
neuropathy; sleep disturbance; caregiver stress (3
daughters with different goals and expectations)

E

91

M

Vascular

Recurrent vertebral fractures; frequent falls; pacing;
resistive to care; distressing delusions; caregiver stress
(daughter)

F

62

M

AD

Aggressive behavior; delusions; hallucinations;
wandering; caregiver stress (spouse undergoing cancer
treatment)

Table 4: Patient characteristics with admitting PPS of 40
Discussion
This study takes an exploratory approach through the journey of hospice care for patients
with dementia. Numerous studies demonstrate that hospice care improves overall outcomes in
this patient population.3,4 However, the issue of hospice eligibility criteria has made it difficult
for patients to enroll. The Palliative Performance Scale is an objective tool that used to assess
patient functionality at the end of life and may be useful in assessments for hospice eligibility.
The first aim of this study was to determine PPS scores at the time of hospice enrollment. As
has been shown in previous studies, PPS for those with dementia showed wide variability at time
of enrollment.12 This supports the prior notion that dementia is a highly variable disease that can
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be difficult to predict. Additionally, the maximum initial PPS was 40, indicating that all patients
were mainly bedridden, and required almost total assistance in providing self-care at the time of
enrollment.
In attempts to correlate PPS with prognosis, it is also important to discuss length of hospice
care. The median LOS for the 53 patients in the study who disenrolled from care was 85 days, or
just under three months. This is similar to previous studies that have explored LOS in hospice for
patients with dementia.9 However, the LOS values had a wide range, from 1 day to just over a
year at 381 days. Once again, this highlights the variability in prognosis for patients with
dementia. To make a hospice referral, a physician must affirm that the patient has a life
expectancy of 6 months or less to meet criteria for enrollment. Our data shows that almost 75%
of the study population died prior to the 6-month mark.
In describing the trends of PPS as a population overall, it is evident that PPS remained
generally constant after an initial 5-point drop in the first 30 days of enrollment. Finally, in
comparing comorbidities and their effects on outcomes, it is interesting to note that for patients
with concurrent Parkinsonism, the average LOS in hospice care was over one month shorter than
average LOS for all other patients.
Conclusion
Findings in this study show a significant linear correlation between initial PPS and LOS
in hospice for patients with dementia. Small sample size is the main limitation. The final sample
size was 55, with two of those patients still currently enrolled in hospice care. Additionally,
demographics were not a main focus of the study, including comparisons in outcomes between
genders and various ethnic groups. It is important to consider that only two etiologies of
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dementia were studied here. There are several other causes of dementia, and that information
would be important to explore in future studies. Finally, the logistics of assessing a patient’s PPS
score may be another limitation. Although PPS is an objective measure of functional decline, it is
important to note that two different providers performing these assessments may not give
identical scores to the same patient. Furthermore, PPS assessments are not always conducted at
regular intervals, which can make it difficult to assess the data accurately.
Future directions for research of this type may include closer investigations into etiology of
dementia and patient comorbidities to assess their specific effects on prognosis. It may also be
valuable to conduct a prospective study to trend PPS over time at regularly spaced intervals for
cleaner analysis. There is still much to be learned when it comes to prognosis for patients with
dementia. As hospice eligibility continues to evolve, finding ways to provide the best possible
care for these vulnerable populations at the end of life should be a priority.
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